Eton Pharmaceuticals signs exclusive US license deal with Aquestive for Libervant seizure rescue film
Eton Pharmaceuticals signed an exclusive U.S. license and supply deal with Aquestive for LIBERVANT (diazepam) buccal film for seizure clusters. Eton targets an April 2027 commercial launch, contingent on final FDA approval. Full approval for patients 12 and older is expected after VALTOCO orphan exclusivity ends on Jan